In the present study, we confirmed that treatment with a MEK162/BKM120 combination effectively inhibited cell proliferation, induced apoptosis, and G0/G1 cell cycle arrest in EGFR-TKI resistant NSCLC cell lines: H1975, H460, and A549. Here, EGFR is linked to non-small cell lung carcinoma.